Neutral
MarketBeat reports that Baxter International Inc. (NYSE:BAX) has received a consensus "Reduce" rating from an average of thirteen brokerages, with an ...
Neutral
Baxter International reported mixed Q1 2026 results with a net loss but revenue and adjusted earnings exceeding analyst expectations. The company reaf...
Bullish
Baxter International Inc. reported strong Q1 2026 results, with revenue of $3.8 billion, a 5% year-over-year increase, and adjusted EPS of $0.68, surp...
This article analyzes whether Baxter International (BAX) is mispriced after a 39% share price increase over the past year. Using Discounted Cash Flow ...
Bullish
Institutional investors are heavily buying Baxter International Inc. (BAX) shares, as indicated by recent 13F filings. Prominent value and contrarian ...
Bullish
Baxter International Inc. (US0673431090) presents a defensive growth profile for investors due to its focus on essential hospital products like renal ...